首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucose transporter
【2h】

Autoantibodies in recent onset type-1 diabetic patients to a Mr 60K microsomal hepatic protein: new evidence for autoantibodies to the type-2 glucose transporter

机译:最近发病的1型糖尿病患者中针对Mr 60K微粒体肝蛋白的自身抗体:2型葡萄糖转运蛋白自身抗体的新证据

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Here we describe the presence of IgG antibodies, in the sera of patients presenting with insulin-dependent diabetes mellitus (IDDM), that react in Western blots with a 60-kD protein (Mr 60K) from rat hepatic microsomal extracts. Sera from 60 IDDM patients were screened and 31·6% were positive for the Mr 60K band. This antibody reactivity was indistinguishable in terms of both molecular weight and isoelectric point (pI 5·4) from that described in some patients presenting with autoimmune hepatitis who may also develop IDDM. We hypothesized that the type-2 glucose transporter (Glut-2) that is expressed on both hepatocytes and pancreatic β cells could be a putative target for the detected antibodies. A polyclonal antisera to rat Glut-2 used in the liver microsome Western blot identified a 60-kD band superimposable upon that evidenced by IDDM sera. Antisera to Glut-2 successfully inhibited the binding of the patient's IgGs to liver microsomes, further suggesting that the two proteins may be identical. Using protein extracts from a rat insulinoma cell line (RIN) transfected with the human Glut-2 cDNA, further evidence was obtained suggesting that these IDDM IgGs are specific for the human Glut-2 transporter.
机译:在这里,我们描述了存在胰岛素依赖型糖尿病(IDDM)的患者血清中IgG抗体的存在,这些抗体在Western印迹中与来自大鼠肝微粒体提取物的60 kD蛋白(Mr 60K)反应。筛选了60例IDDM患者的血清,Mr 60K带阳性的率为31.6%。在分子量和等电点(pI 5·4)方面,该抗体的反应性与某些自身免疫性肝炎也可能发展为IDDM的患者所描述的反应性没有区别。我们假设在肝细胞和胰腺β细胞上表达的2型葡萄糖转运蛋白(Glut-2)可能是检测到的抗体的假定靶标。在肝脏微粒体Western印迹中使用的针对大鼠Glut-2的多克隆抗血清确定了一个60 kD条带,该条带可与IDDM血清所证明的条带重叠。针对Glut-2的抗血清成功抑制了患者IgG与肝微粒体的结合,进一步表明这两种蛋白可能是相同的。使用转染了人Glut-2 cDNA的大鼠胰岛素瘤细胞系(RIN)的蛋白质提取物,获得了进一步的证据,表明这些IDDM IgG对人Glut-2转运蛋白具有特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号